UNSPSC 51283800: Streptogramins

This classification denotes a class of natural cyclic peptide antibiotics produced by certain subspecies of streptomyces, hence the name STREPTO-GRAMIN, STREPTO-GRAMINS, and STREPTOGRAMINS. They include two structurally unrelated components, streptogramin group a and streptogramin group b, which generally act synergistically to inhibit bacterial growth.

UNSPSC 51283800 Streptogramins is a Class code, but the recent state and local opportunities tagged under it do not align with the code's pharmaceutical scope. The named solicitations—naloxone and drug deactivation systems, direct-to-manufacturer prescriptions, medical and first aid supplies for fire rescue, and generic multi-source pharmaceuticals and OTC products—fall outside streptogramin antibiotic procurement and suggest either a data-tagging error in the source or use of the code as a broader pharmaceutical catch-all by some issuing bodies. State and local governments sourcing under this code nominally purchase streptogramin antibiotics, but current activity reflects wider pharmacy and medical supply procurement by county health departments, state health agencies, city fire departments, and multi-state cooperative purchasing alliances.

The geographic spread of recent opportunities spans Florida, Texas, Minnesota, and Oregon through cooperative vehicles and local government purchasing. Seminole County, Florida issued IFB 60459723LAS for naloxone and drug deactivation systems with a response deadline of July 26, 2023; the Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, exploring direct-to-manufacturer prescription capabilities; the City of Tampa released IFB 26P00145 on March 25, 2026, for medical and first aid supplies supporting the Fire Department Rescue Division, with an estimated contract value of $700,000 and a certified Small Local Business Enterprise set-aside; and the Minnesota Department of Administration's Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products, with responses due March 26, 2026. The MMCAP procurement is available to participating state and local government facilities across multiple states. Code activity shows mixed signals—issuing bodies appear to use it inconsistently, and actual streptogramin-specific procurement is not evident in the recent record.